In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Nicaragua gets US help with new central laboratory:

This article was originally published in Clinica

Executive Summary

The US government is supplying the Nicaraguan health ministry with the laboratory equipment, reagents and other disposables needed to ensure it is able to monitor outbreaks of avian flu. The donation, which is being co-ordinated through the Central American state's US embassy, supports the establishment of the national diagnostic reference centre (CNDR). Announcing the initiative, health minister Maritza Cuan also welcomed an offer from the US Centers for Disease Control and Prevention (CDC), in Atlanta, as part of the WHO's network of reference testing centres, to perform the more specialised (viral sequencing) testing of samples, which Nicaragua will not be able to perform at the CNDR. Citing the views of US experts currently training staff for the centre, Dr Cuan said that the CNDR is set to significantly help improve the technical quality and speed of detection of diseases generally.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049580

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel